KUBOTA PHARMACEUTICAL HOLDINGS CO LTD - FORM 10-K - EX-32.1 - CERTIFICATION - March 30, 2015

Attached files

file filename
10-K - 10-K - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231x10k.htm
EX-23.01 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDa0002-consentofindependent.htm
EX-10.20 - FORM OF SEVERANCE AND CHANGE IN EFFECTIVE CONTROL AGREEMENT - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_xseverancexandxcha.htm
EX-10.21 - 2014 EQUITY INCENTIVE PLAN (AS AMENDED) - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2014xequityxincent.htm
EX-10.23 - 2002 STOCK OPTION PLAN/RESTRICTED STOCK PLAN LETTER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2002xplanxletterxp.htm
EX-10.22 - 2012 EQUITY INCENTIVE PLAN LETTER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela_2012xplanxletterxp.htm
EX-32.2 - CERTIFICATION - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit322.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit312.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDacucela-20141231xexhibit311.htm
EXCEL - IDEA: XBRL DOCUMENT - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDFinancial_Report.xls
EX-10.19 - FIRST AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE CO. AND BRIAN O'CALLAGHAN - KUBOTA PHARMACEUTICAL HOLDINGS CO LTDo_callaghanxfirstxamendmen.htm
Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 


I, Brian O'Callaghan, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, the Annual Report of Acucela Inc. on Form 10-K for the year ended December 31, 2014 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as applicable, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Acucela Inc. for the periods presented therein.


Date:
March 30, 2015
 
/s/ Brian O'Callaghan
 
 
 
Chief Executive Officer and President
 
 
 
(Principal Executive Officer)




KUBOTA PHARMACEUTICAL HOLDINGS CO LTD Reports